UROTHELIAL CARCINOMA BLADDER
Clinical trials for UROTHELIAL CARCINOMA BLADDER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA BLADDER trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive 'Smart Bomb' targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new radioactive drug that seeks out a protein called Nectin-4 on cancer cells. It is for people with advanced solid tumors (like bladder, breast, lung, or cervical cancer) that have not responded to prior treatments. The main goals are to find a saf…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
New shot for bladder tumors shows promise in early trial
Disease control Recruiting nowThis early-stage study is testing a new drug, belzupacap sarotalocan, injected directly into bladder tumors to see if it's safe and doable for people with non-muscle-invasive bladder cancer. About 55 participants will receive the injection, sometimes with a laser, and be monitore…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New tool may spare Women's organs during bladder cancer surgery
Disease control Recruiting nowThis study tests a decision tool to identify women with bladder cancer who may safely keep their reproductive organs during bladder removal surgery. Currently, standard surgery removes the bladder along with the uterus, ovaries, and part of the vagina, which can harm sexual healt…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 15, 2026 12:05 UTC
-
New virus therapy targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new experimental treatment called VET3-TGI, a virus designed to attack cancer cells. It is given alone or with an immunotherapy drug (atezolizumab) to about 60 adults with advanced solid tumors that have not responded to standard treatments. The mai…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE1 • Sponsor: KaliVir Immunotherapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New bladder cancer drug aims to match gold standard in major trial
Disease control Recruiting nowThis Phase 3 trial tests a new treatment called VERITY-BCG for people with intermediate or high-risk non-muscle invasive bladder cancer who have not received BCG therapy before. The study compares VERITY-BCG to the standard BCG treatment (OncoTICE) to see if it works just as well…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE3 • Sponsor: Verity Pharmaceuticals Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug combo aims to save kidneys in rare cancer patients who skip surgery
Disease control Recruiting nowThis study tests a combination of two cancer drugs, enfortumab vedotin and pembrolizumab, in 20 people with high-grade upper tract urothelial cancer (a rare cancer of the kidney and ureter). Participants are those who cannot or choose not to have standard surgery to remove the ki…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Engineered immune cells take on advanced bladder cancer
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (4SCAR-T cells) in people with advanced bladder cancer that has spread and has no other treatment options. About 20 participants will receive the cells to see if they can shrink tumors and improve survival. …
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Simple urine test could replace painful scope for bladder cancer detection
Diagnosis Recruiting nowThis study is testing a new urine test called Bladder EpiCheck to see if it can accurately detect bladder cancer in people aged 45 and older who have blood in their urine. The test results will be compared to the standard procedure, cystoscopy, which uses a camera to look inside …
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Sponsor: Nucleix Ltd. • Aim: Diagnosis
Last updated Apr 26, 2026 19:36 UTC
-
Step up to surgery: daily walking may cut bladder cancer operation risks
Symptom relief Recruiting nowThis study looks at whether walking 8,000 to 10,000 steps each day for four weeks before bladder cancer surgery can lower the chance of problems after the operation. About 146 adults with bladder cancer who are scheduled for surgery will take part. Half will be asked to increase …
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: NA • Sponsor: Ludwig-Maximilians - University of Munich • Aim: Symptom relief
Last updated May 17, 2026 03:13 UTC